Hikma Pharmaceuticals PLC
(LSE:HIK)
£
18.31
0.3 (1.67%)
Market Cap: 4.06 Bil
Enterprise Value: 4.80 Bil
PE Ratio: 27.57
PB Ratio: 2.36
GF Score: 90/100 
Full Year 2023 Hikma Pharmaceuticals PLC Earnings Presentation (Pre-Recorded) Transcript
Feb 22, 2024 / 07:00AM GMT
Release Date Price:
£20.83
(+4.28%)
Riad Mishlawi
Hikma Pharmaceuticals PLC - Member of the Executive Committee, President, Injectables
Presentation (Pre-Recorded)
Feb 22, 2024 / 07:00AM GMT
=====================
Corporate Participants
=====================
* Riad Mishlawi
Hikma Pharmaceuticals PLC - Member of the Executive Committee, President, Injectables
* Khalid Nabilsi
Hikma Pharmaceuticals PLC - Chief Financial Officer, Member of the Executive Committee
=====================
-
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers